Supplement Interactions
Biotin and Lab Tests
A hair and nail supplement that can make your thyroid results say something that is not true.
Evidence: Well documented
Biotin, vitamin B7, is used in the chemistry of many immunoassays, so high-dose supplementation can produce falsely high or falsely low results depending on the assay format. A 2016 case report and literature review in the Journal of Clinical Endocrinology and Metabolism described a patient whose thyroid results mimicked Graves disease and normalised after biotin was stopped, far faster than the half-life of T4 could explain. The interference is not limited to thyroid tests.
The mechanism, in plain terms
This is not a nutrient interaction. Biotin is not doing anything to your body here. It is interfering with the test.
Many laboratory immunoassays are built using an extremely strong binding pair: biotin and streptavidin. That bond is one of the strongest non-covalent interactions known in biology, which is exactly why assay designers use it to anchor components of the test together.
The problem is straightforward once you see it. If your blood sample arrives carrying a large amount of free biotin, that free biotin competes for the streptavidin binding sites the assay was relying on.
What happens next depends on how the particular test is built. In some assay formats the interference produces a falsely high result. In others, a falsely low one.
That unpredictability is what makes this worth knowing rather than shrugging at. You cannot look at a result and tell whether biotin pushed it up or down without knowing the assay design.
And the interference is not confined to thyroid tests. The same chemistry is used across a wide range of immunoassays.
What actually happens to people
The clearest documented example is a thyroid one, and it is worth walking through because the detective work is instructive.
A 2016 case report and systematic review of the literature in the Journal of Clinical Endocrinology and Metabolism, from a tertiary endocrine service in New Zealand, described a patient with markedly abnormal thyroid function tests that did not match the clinical picture at all. The results looked like Graves disease.
After biotin was stopped, the thyroid results normalised far more rapidly than was possible given the half-life of T4.
That detail is what gave it away. T4 has a half-life of about a week, so genuine thyroid hormone levels cannot swing back that quickly. The only explanation consistent with the speed was that the numbers had never reflected real hormone levels in the first place.
Multiple other analytes also tested abnormal in the presence of biotin, which is the part people miss when they file this under thyroid.
The review's conclusion was that biotin ingested in moderate to high doses can cause immunoassay interference, that depending on assay format it can result in either falsely high or falsely low values, and that interference is not limited to thyroid tests.
The context that makes this practically important: high-dose biotin, at levels many thousands of times the recommended daily intake, has been used in progressive multiple sclerosis, and low to moderate doses are a common component of multivitamin and hair, skin and nail preparations. So the exposure is widespread and mostly invisible to whoever is interpreting the result.
The doses and durations that show up
The recommended daily intake of biotin is around 30 micrograms. Hair, skin and nail supplements commonly contain 5,000 or 10,000 micrograms, which is well over a hundred times that.
So the doses causing interference are not exotic. They are what is sitting on a great many bathroom shelves, taken by people who have no idea it affects anything.
The good news is that biotin is water soluble and clears reasonably quickly. Pausing it for a couple of days before a blood draw is generally enough to remove the interference, and that is the standard practical advice.
That said, the exact interval worth leaving depends on the dose and on the assay, so it is genuinely a question for your ordering provider or the lab rather than a number to fix from a website. Very high doses may warrant longer.
The most important variable is not the duration at all. It is whether anyone knows you are taking it, because a false result acted upon is the actual harm here.
The honest hedge
I am not a doctor and I am not diagnosing anyone.
I want to be clear that this is not an argument against biotin as a nutrient. It is a required vitamin, deficiency is real if uncommon, and nothing here says taking it is harmful to you.
What it says is that taking it can make your lab results describe someone else, and that a doctor acting on a false result is where the actual risk lies. Being started on treatment for a thyroid condition you do not have, or being reassured about one you do, are both genuinely consequential.
The second thing worth saying: do not stop a prescribed high-dose biotin regimen on your own. If it was prescribed, the interference is a testing logistics problem for your care team to manage rather than a reason to discontinue treatment.
There is a broader principle here that outlives this specific vitamin. Whoever interprets your labs can only account for what they know about, and supplements are the category people most consistently forget to mention. Biotin is simply the clearest documented example of why that matters.
And if a lab result ever seems wildly at odds with how you actually feel, that mismatch is worth raising rather than accepting. In the case above, the mismatch is precisely what prompted the investigation.
So. What to actually do.
Tonight, at no cost. Read the labels on everything you take and look for biotin, listed sometimes as vitamin B7 or vitamin H. Check multivitamins, hair and nail products, and collagen blends, and note the microgram amount.
Pause it before a blood draw, with your provider's agreement. A couple of days is the usual advice, and the exact interval is worth confirming with whoever ordered the test.
Tell the phlebotomist and your ordering provider either way. Even if you did pause it, they are entitled to know it is in your routine.
Apply it beyond thyroid. The interference is not limited to thyroid tests, so mention it whatever you are having measured.
If a result does not match how you feel, say so. That mismatch is what uncovered the documented case, and it is a legitimate thing to raise.
Do not stop a prescribed high-dose regimen yourself. That is a logistics question for your care team, not a reason to discontinue treatment.
Read your thyroid results properly once they are clean. The thyroid panel page covers what each number actually answers.
None of this has to happen this week. But tonight you can check whether biotin is in anything on your shelf.
You are not the number on the report. You are the person the number was supposed to describe, and occasionally something in a capsule gets in between the two.
Your body is not broken. It is blocked. And in this case the block is not even in you, it is in the chemistry of the test, which is the cheapest kind of block there is to remove.
Go read your labels.
Read these alongside it
The marker where biotin interference shows up most often.
What each thyroid number actually answers, once the result is clean.
The screening number, and what it can and cannot see.
Why people are taking biotin in the first place, and what actually drives shedding.
Every pairing, each with an evidence tier.
Know what interacts with what
Occasional notes on the pairings worth knowing about, the mechanisms behind them, and how strong the evidence actually is.
Questions
Does biotin affect thyroid tests?›
How long should I stop biotin before a blood test?›
Which lab tests does biotin interfere with?›
How much biotin causes interference?›
Does biotin make my results high or low?›
Should I stop taking biotin altogether?›
What if my thyroid result does not match how I feel?›
References
- Elston MS, et al. Factitious Graves' Disease Due to Biotin Immunoassay Interference, A Case and Review of the Literature. The Journal of Clinical Endocrinology and Metabolism. 2016. PMID 27362288
- Andersen S, et al. Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. The Journal of Clinical Endocrinology and Metabolism. 2002. PMID 11889165
- Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. The Journal of Clinical Endocrinology and Metabolism. 2005. PMID 16148345